IL18 and Stroke: Interleukin-18 (IL-18) and interleukin-12 (IL-12) are pro-inflammatory cytokines whose levels are elevated after stroke and are associated with worse clinical outcomes due to their role in enhancing Th1 responses and innate immune activation.